Invention Application
- Patent Title: ANTI-FCRN ANTIBODIES
-
Application No.: US15573185Application Date: 2016-05-09
-
Publication No.: US20180127498A1Publication Date: 2018-05-10
- Inventor: Pallavi BHATTA , Emma DAVE , Sam Philip HEYWOOD , David Paul HUMPHREYS , Bryan John SMITH
- Applicant: UCB Biopharma SPRL
- Applicant Address: BE Brussels
- Assignee: UCB Biopharma SPRL
- Current Assignee: UCB Biopharma SPRL
- Current Assignee Address: BE Brussels
- Priority: GB1508180.5 20150513
- International Application: PCT/EP2016/060305 WO 20160509
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/18 ; A61P21/04 ; A61P17/00 ; A61P25/00 ; A61P37/00 ; A61P7/00
Abstract:
The disclosure relates to antibody fusion proteins specific to FcRn, formulations comprising the same, use of each in therapy, processes for expressing and optionally formulating said antibody, DNA encoding the antibodies and hosts comprising said DNA.
Information query
